These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6110)

  • 1. Clinical application of antipyrine half life in saliva in a patient with osteomalacia.
    Fraser HS; Thompson D; Khan C
    Br Med J; 1976 Jun; 1(6024):1507-8. PubMed ID: 6110
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiopyrine half-life as a measure of hepatic enzyme induction: clinical applications in a chronic epileptic population.
    Byrne E; Harman AW; Frewin DB; Hallpike JF
    Clin Exp Neurol; 1979; 16():183-9. PubMed ID: 550940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barbiturate and anticonvulsant treatment in relation to osteomalacia with haemodialysis and renal transplantation.
    Pierides AM; Ellis HA; Ward M; Simpson W; Peart KM; Alvarez-ude F; Uldall PR; Kerr DN
    Br Med J; 1976 Jan; 1(6003):190-3. PubMed ID: 764921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteomalacia after prolonged glutethimide administration.
    Greenwood RH; Prunty FT; Silver J
    Br Med J; 1973 Mar; 1(5854):643-5. PubMed ID: 4144245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone--a weak enzyme inducer in man.
    Taylor SA; Rawlins MD; Smith SE
    J Pharm Pharmacol; 1972 Jul; 24(7):578-9. PubMed ID: 4403853
    [No Abstract]   [Full Text] [Related]  

  • 6. Spironolactone and enzyme induction in patients with alcoholic cirrhosis.
    Miguet JP; Vuitton D; Thebault-Lucas A; Joanne C; Dhumeaux D
    Gastroenterology; 1980 May; 78(5 Pt 1):996-1000. PubMed ID: 7380205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of combined pre-treatment on the metabolism of antipyrine in the rat.
    Szabó I; Renczes G; Gachályi B
    Acta Physiol Hung; 1995; 83(1):51-3. PubMed ID: 7660837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barbiturates and fractures.
    Br Med J; 1977 Sep; 2(6087):640. PubMed ID: 902019
    [No Abstract]   [Full Text] [Related]  

  • 9. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV; Sotaniemi EA
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative investigation of antipyrine half-life and induction of cytochrome P-450 dependent monooxygenases in rats treated with phenylurea herbicides.
    Schoket B; Zilahy Z; Molnar J; Vincze I
    In Vivo; 1987; 1(3):185-7. PubMed ID: 2979785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A re-evaluation of intersubject variation in enzyme induction in man.
    Branch RA; Shand DG
    Clin Pharmacokinet; 1979; 4(2):104-10. PubMed ID: 455871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of spironolactone on antipyrine metabolism in man.
    Huffman DH; Shoeman DW; Pentikäinen P; Azarnoff DL
    Pharmacology; 1973; 10(6):338-44. PubMed ID: 4593769
    [No Abstract]   [Full Text] [Related]  

  • 13. Salivary antipyrine half-life during injectable progestagen contraception.
    Joshi JV; Gupta KC; Hazari KT; Gokral J; Pohujani S; Satoskar R
    Clin Pharmacokinet; 1986; 11(2):171-5. PubMed ID: 3956050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis therapy and enzyme induction in man.
    Larousse C; Le Normand Y; Kergueris MF; Veyrac MJ; Chailleux E; Ordronneau J; Moigneteau C
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):163-8. PubMed ID: 7380590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An attempt at assessment of biotransformation activity in calves' liver on the basis of the rate of antipyrine elimination from saliva].
    Janus K; Baranow-Baranowski S; Jakubowska D
    Pol Arch Weter; 1991; 31(3-4):65-71. PubMed ID: 1842615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal drug metabolism following barbiturate and paracetamol overdosage.
    Forrest AH; Roscoe P; Stevenson IH; Prescott LF
    Scott Med J; 1974 May; 19(3):157. PubMed ID: 4829646
    [No Abstract]   [Full Text] [Related]  

  • 17. Antipyrine clearance during occupational exposure to styrene.
    Døssing M
    Br J Ind Med; 1983 May; 40(2):224-8. PubMed ID: 6131688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vertebral compression in drug addicts].
    Dally S; Audisio F
    Nouv Presse Med; 1978 Apr; 7(15):1299. PubMed ID: 662660
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive gas-chromatographic assay using a nitrogen-phosphorus detector for determination of antipyrine and aminopyrine in biological fluids.
    Shively CA; Simons RJ; Vesell ES
    Pharmacology; 1979; 19(5):228-36. PubMed ID: 538077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.